Recent Quotes

My Watchlist

Indicators

Aethlon Medical, Inc. - Common Stock (NQ:AEMD)

0.3660 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	28
Open	0.3660
Bid (Size)	0.3600 (1)
Ask (Size)	0.3920 (2)
Prev. Close	0.3660
Today's Range	0.3660 - 0.3660
52wk Range	0.2375 - 1.250
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Tuesday's After-Market Session

April 08, 2025

Via Benzinga

Earnings Scheduled For February 12, 2025

February 12, 2025

Via Benzinga

Performance

YTD	-54.3%	-54.3%
1 Month	+6.4%	+6.4%
3 Month	-46.1%	-46.1%
6 Month	-14.3%	-14.3%
1 Year	-63.2%	-63.2%

More News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

January 02, 2025

Via Benzinga

Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

January 02, 2025

Via Benzinga

Earnings Scheduled For November 13, 2024

November 13, 2024

Via Benzinga

An Overview of Aethlon Medical's Earnings

November 12, 2024

Via Benzinga

(AEMD) - Analyzing Aethlon Medical's Short Interest

June 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session

December 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session

December 19, 2024

Via Benzinga

US Stocks Higher, Micron Reports Downbeat Sales

December 19, 2024

Via Benzinga

Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

December 19, 2024

Via Benzinga

Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

November 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

October 09, 2024

Via Benzinga

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

September 20, 2024

From Virtual Investor Conferences

Via GlobeNewswire

Immunotherapy Clinical Trials - A New Approach to Treating Cancer

September 19, 2024

Via Newsfile

Innovation Driving Cancer's Solid Tumors Market

September 17, 2024

Via Newsfile

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

September 16, 2024

From Virtual Investor Conferences

Via GlobeNewswire

Aethlon Medical to Present at the Life Sciences Investor Forum September 19th

September 13, 2024

From Virtual Investor Conferences

Via GlobeNewswire

Why Nordstrom Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

August 28, 2024

Via Benzinga

Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

August 15, 2024

Via Benzinga

AEMD Stock Earnings: Aethlon Medical Misses EPS for Q1 2025

August 14, 2024

Via InvestorPlace

The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors

August 12, 2024

Via Newsfile

AEMD Stock Earnings: Aethlon Medical Beats EPS for Q4 2024

June 27, 2024

Via InvestorPlace

What's Next in Treatments for Cancer Patients with Solid Tumors?

June 20, 2024

Via Newsfile

12 Health Care Stocks Moving In Friday's Pre-Market Session

June 14, 2024

Via Benzinga

Frequently Asked Questions

Is Aethlon Medical, Inc. - Common Stock publicly traded?

Yes, Aethlon Medical, Inc. - Common Stock is publicly traded.

What exchange does Aethlon Medical, Inc. - Common Stock trade on?

Aethlon Medical, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aethlon Medical, Inc. - Common Stock?

The ticker symbol for Aethlon Medical, Inc. - Common Stock is AEMD on the Nasdaq Stock Market

What is the current price of Aethlon Medical, Inc. - Common Stock?

The current price of Aethlon Medical, Inc. - Common Stock is 0.3660

When was Aethlon Medical, Inc. - Common Stock last traded?

The last trade of Aethlon Medical, Inc. - Common Stock was at 05/09/25 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.